What is Zacks Research’s Forecast for TSE:BHC Q1 Earnings?

Bausch Health Companies Inc. (TSE:BHC) – Equities research analysts at Zacks Research reduced their Q1 2026 earnings estimates for shares of Bausch Health Companies in a report released on Wednesday, March 11th. Zacks Research analyst Team now forecasts that the company will post earnings of $1.10 per share for the quarter, down from their previous forecast of $1.13. The consensus estimate for Bausch Health Companies’ current full-year earnings is $5.55 per share. Zacks Research also issued estimates for Bausch Health Companies’ Q3 2026 earnings at $1.44 EPS, Q4 2026 earnings at $1.49 EPS, FY2026 earnings at $5.32 EPS, Q1 2027 earnings at $1.11 EPS, Q2 2027 earnings at $1.20 EPS, Q4 2027 earnings at $1.32 EPS and FY2027 earnings at $5.15 EPS.

Several other equities research analysts also recently commented on the company. Raymond James Financial raised Bausch Health Companies to a “hold” rating in a report on Monday, December 15th. Barclays upgraded shares of Bausch Health Companies to a “hold” rating in a report on Monday, December 8th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Bausch Health Companies has a consensus rating of “Hold”.

Bausch Health Companies Stock Up 0.5%

TSE:BHC opened at C$7.37 on Thursday. Bausch Health Companies has a twelve month low of C$5.91 and a twelve month high of C$11.97. The firm has a market capitalization of C$2.73 billion, a price-to-earnings ratio of 17.55, a price-to-earnings-growth ratio of 0.21 and a beta of 0.60. The company has a quick ratio of 0.58, a current ratio of 1.47 and a debt-to-equity ratio of -3,835.02. The stock’s 50 day moving average price is C$8.62 and its two-hundred day moving average price is C$9.09.

Bausch Health Companies (TSE:BHC) last released its earnings results on Wednesday, February 18th. The company reported C($0.41) earnings per share (EPS) for the quarter. Bausch Health Companies had a negative return on equity of 20.27% and a net margin of 1.82%.The company had revenue of C$6.62 billion for the quarter.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.